Image de couverture de Taking Control Of Your Diabetes® - The Podcast!

Taking Control Of Your Diabetes® - The Podcast!

Taking Control Of Your Diabetes® - The Podcast!

De : Taking Control Of Your Diabetes®
Écouter gratuitement

La meilleure offre de la saison | 0,99 €/mois pendant les 3 premiers mois + 15 € de crédit Audible

6,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.
À propos de ce titre
Welcome to Taking Control Of Your Diabetes® - The Podcast, an edutaining show all about highs and lows of living with diabetes. Hosted by Dr. Steve Edelman and Dr. Jeremy Pettus, both endocrinologists who have been living with diabetes themselves since they were 15, we’re discussing the important topics that people living with diabetes need to know—and no topic is off-limits. From the latest advancements in diabetes medications and devices, to interviews with some of the best minds in diabetes, to personal stories about the ups and downs of dealing with this condition 24/7, we’re tackling what it means to live with diabetes in modern times. And we promise to make you laugh along the way, because sometimes we just need to laugh at the craziness that comes with living with diabetes. Tune in for a new episode on the last Monday of every month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes! VISIT: tcoyd.org | FOLLOW: tcoyd.org/contact | EMAIL: podcast@tcoyd.org APPLE PODCAST RATING: 4.9/🌟🌟🌟🌟🌟Taking Control Of Your Diabetes® Hygiene & gesundes Leben Seelische & Geistige Gesundheit
épisodes
  • Diabetes and Your Eyes: Why Clear Vision Isn’t Enough
    12 Nov 2026


    Diabetic eye disease can develop without any noticeable symptoms, but that doesn't mean vision loss is inevitable. With regular eye exams, early detection, and advances in treatment, people living with diabetes have more options than ever to protect their eyesight and prevent serious complications.


    In this episode, Dr. Steve Edelman sits down with Dr. Eric Nudelman, a retina specialist and associate professor at UC San Diego's Shiley Eye Institute, to discuss how diabetes affects the eyes and what people living with type 1 and type 2 diabetes can do to preserve their vision. Drawing from his own experience living with diabetic retinopathy and macular edema, Dr. Edelman shares his personal journey with laser treatments, eye injections, and the advances in care that have helped stabilize his vision.


    The conversation begins with the basics of diabetic eye disease, including the differences between diabetic retinopathy and diabetic macular edema. Dr. Nudelman explains how diabetes can damage the small blood vessels in the retina, leading to swelling, leakage, and abnormal blood vessel growth. They also discuss why eye damage can occur long before someone notices blurry vision or other symptoms, making routine screening especially important. Dr. Nudelman walks through when people living with type 1 and type 2 diabetes should begin getting eye exams, how often follow-up visits may be needed, and what to expect during a comprehensive retinal examination.


    Dr. Edelman and Dr. Nudelman also explore how treatments for diabetic eye disease have evolved over the years. From traditional laser therapy to modern anti-VEGF injections, they explain how these treatments work, when they're recommended, and how they help prevent vision loss. Dr. Nudelman breaks down what actually happens during an eye injection, why the procedure is generally much less uncomfortable than people expect, and how newer medications and longer-lasting treatment options are helping reduce the burden of frequent injections. They also discuss alternative treatments for diabetic macular edema, including steroids and sustained-release therapies.


    Beyond treatment, they emphasize the importance of managing blood sugar, blood pressure, and cholesterol to help reduce the risk of diabetic eye disease progression. Dr. Nudelman explains why keeping up with regular eye appointments is just as important as managing glucose levels, even when vision seems perfectly normal.


    Finally, they look ahead at promising developments in diabetic eye care, including new medications targeting the Wnt signaling pathway and other approaches that could provide additional options for people who don't respond fully to current treatments. Throughout the conversation, Dr. Edelman and Dr. Nudelman reinforce an encouraging message: diabetic eye disease is serious, but early detection, consistent monitoring, and effective treatment can make a tremendous difference in protecting your vision for the long term.


    Key Topics

    • How diabetes affects the retina and blood vessels in the eyes
    • The difference between diabetic retinopathy and diabetic macular edema
    • Nonproliferative vs. proliferative diabetic retinopathy
    • Why diabetic eye disease can develop without symptoms
    • When to start getting diabetic eye exams
    • Recommended screening and follow-up intervals for type 1 and type 2 diabetes
    • What to expect during a comprehensive retinal exam
    • How retinal photography and OCT imaging help detect eye damage
    • When diabetic retinopathy requires monitoring vs. treatment
    • The role of VEGF in abnormal blood vessel growth and leakage
    • How laser treatments work and their effects on peripheral and night vision
    • How anti-VEGF injections have changed diabetic eye disease treatment
    • What happens during an eye injection
    • Treating diabetic macular edema with anti-VEGF medications and steroids
    • Longer-lasting treatments and refillable drug delivery systems
    • The importance of blood sugar, blood pressure, and cholesterol management
    • Why early detection and consistent eye care are essential
    • Emerging treatments targeting the Wnt signaling pathway
    • The future of diabetic eye disease prevention and treatment

    ★ Support this podcast ★
    afficher plus Afficher moins
    29 min
  • What’s Next for GLP-1s?
    26 Oct 2026


    GLP-1 medications have come a long way since the first one became available in 2005, and the next generation could bring even more options for people living with diabetes. From pills to medications that combine multiple hormones, GLP-1s continue to evolve beyond glucose management and weight loss.


    In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus discuss how GLP-1 medications have evolved and where they may be headed next. They look back at the progression from early twice-daily injections to once-weekly therapies and explain how the role of GLP-1s has expanded from managing glucose to supporting weight management, cardiovascular health, kidney health, and other areas of metabolic health.


    The conversation explores newer oral GLP-1 options and what taking a pill instead of an injection could mean for people who prefer that option. Dr. Edelman and Dr. Pettus also discuss the next generation of therapies that combine GLP-1 with hormones such as GIP, glucagon, and amylin. They explain why researchers are combining these different hormones, how they may affect weight and glucose, and why getting to the highest possible dose isn’t necessarily the goal for everyone.


    They also address some of the practical questions that come with taking a GLP-1, including side effects, cost, insurance coverage, and whether these medications need to be taken long term. The discussion covers nausea and other GI side effects, concerns about losing muscle and lean mass during significant weight loss, and why getting enough protein and staying physically active can be important. They also explain what can happen when GLP-1 therapy is stopped, including the possibility of regaining weight.


    Finally, Dr. Edelman and Dr. Pettus discuss what GLP-1 medications could mean for people living with type 1 diabetes. They share their clinical experience using these medications in people with type 1 diabetes for other indications and discuss ongoing research looking at their potential effects on weight, insulin needs, A1C, and glucose variability. They also look at how future approvals could affect insurance coverage and what continued innovation may mean for people living with diabetes.


    Key Topics

    • How GLP-1 medications have evolved and where they’re headed next
    • Benefits beyond glucose management and weight loss
    • Oral GLP-1 medications vs. injections
    • Next-generation therapies combining multiple hormones
    • The role of GIP, glucagon, and amylin
    • Why the highest dose isn’t necessary for everyone
    • Setting realistic goals for weight loss and glucose management
    • What happens when GLP-1 therapy is discontinued
    • Managing GI side effects
    • Muscle loss, protein intake, and physical activity
    • Emerging GLP-1 research in type 1 diabetes
    • How GLP-1s may affect insulin needs and glucose variability
    • Cost, insurance coverage, and access
    • The future of GLP-1 therapy

    ★ Support this podcast ★
    afficher plus Afficher moins
    36 min
  • Once-Weekly Insulin: Most Exciting Advance in Years?
    8 Oct 2026

    What if you could take your basal insulin once a week instead of every day? Once-weekly basal insulin has arrived, offering a new approach that could make insulin therapy simpler while providing glucose control comparable to daily basal insulin.

    In this episode, Dr. Steve Edelman is joined by Dr. Athena Philis-Tsimikas, a leading diabetes researcher who has been directly involved in clinical trials of once-weekly basal insulins. Together, they explain how these ultra-long-acting insulins work, how a single injection can provide steady background insulin throughout an entire week, and what studies have shown when once-weekly insulin is compared with traditional daily basal insulin.

    The conversation gets practical with how once-weekly insulin is started, adjusted, and switched from daily basal insulin. Dr. Edelman and Dr. Philis-Tsimikas discuss the dosage differences with once-weekly basal insulin, how concentrated insulin keeps the actual injection volume small, and how fasting glucose can help guide dose adjustments. They also discuss what happens if you miss a dose and why reaching a steady state is an important part of understanding how these longer-acting insulins work.

    They also dive into the clinical trial results, including A1C, time in range, and hypoglycemia. In studies of people living with type 2 diabetes, once-weekly basal insulin provided similar A1C lowering to daily basal insulin without an increase in hypoglycemia. They also explain why the story is different for people living with type 1 diabetes, where studies found higher rates of hypoglycemia with weekly basal insulin, and what that means for its use in the United States.

    Finally, Dr. Edelman and Dr. Philis-Tsimikas look at how once-weekly insulin could make diabetes management easier. Going from seven basal injections a week to just one could help reduce some of the daily burden of diabetes and make it easier to consistently take your insulin. They also explore using weekly insulin alongside GLP-1 medications, potential combination therapies, cost and access, and what we still need to learn as these newer insulins move from clinical trials into everyday diabetes care.

    Key Topics:

    • How once-weekly basal insulin works
    • Once-weekly vs. daily basal insulin
    • Starting, dosing, and adjusting weekly insulin
    • Why weekly insulin doses may look surprisingly large
    • A1C, time in range, and hypoglycemia results
    • What to do if you miss a weekly dose
    • Once-weekly insulin in type 1 vs. type 2 diabetes
    • Who may benefit from once-weekly insulin?
    • Reducing the burden of daily injections
    • Using once-weekly insulin with GLP-1 medications
    • Future insulin and GLP-1 combination therapies
    • Cost, access, and real-world considerations
    • What the future of basal insulin could look like

    This episode was supported by Lilly.

    ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

    More diabetes resources:
    Website: tcoyd.org
    Blog: tcoyd.org/blog
    Podcast: tcoydthepodcast.transistor.fm
    Instagram: / tcoyd
    Facebook: / tcoyd

    Stay connected! Sign up for our monthly newsletter here!
    Support TCOYD's educational programs: tcoyd.org/donate

    ★ Support this podcast ★
    afficher plus Afficher moins
    29 min
adbl_web_anon_alc_button_suppression_t1
Aucune critique pour le moment